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Previous studies suggested that both robot-assisted rehabilitation and non-invasive brain
stimulation can produce a slight improvement in severe chronic stroke patients. It is
still unknown whether their combination can produce synergistic and more consistent
improvements. Safety and efficacy of this combination has been assessed within a
proof-of-principle, double-blinded, semi-randomized, sham-controlled trial. Inhibitory
continuous Theta Burst Stimulation (cTBS) was delivered on the affected hemisphere, in
order to improve the response to the following robot-assisted therapy via a homeostatic
increase of learning capacity. Twenty severe upper limb-impaired chronic stroke patients
were randomized to robot-assisted therapy associated with real or sham cTBS, delivered
for 10 working days. Eight real and nine sham patients completed the study. Change
in Fugl-Meyer was chosen as primary outcome, while changes in several quantitative
indicators of motor performance extracted by the robot as secondary outcomes. The
treatment was well-tolerated by the patients and there were no adverse events. All
patients achieved a small, but significant, Fugl-Meyer improvement (about 5%). The
difference between the real and the sham cTBS groups was not significant. Among
several secondary end points, only the Success Rate (percentage of targets reached by
the patient) improvedmore in the real than in the sham cTBS group. This study shows that
a short intensive robot-assisted rehabilitation produces a slight improvement in severe
upper-limb impaired, even years after the stroke. The association with homeostatic
metaplasticity-promoting non-invasive brain stimulation does not augment the clinical
gain in patients with severe stroke.
Keywords: stroke recovery, robot-assisted rehabilitation, non-invasive brain stimulation, homeostatic plasticity,
robotic assessment of motor performance
Di Lazzaro et al. Robot Plus Neuromodulation in Stroke
INTRODUCTION
Severe upper limb impairment in chronic stroke patients does
not respond to standard rehabilitation strategies; for this reason
there is the need of new treatments that might be effective in
patients with drastically limited residual movement capacity.
In patients with moderate to severe upper-limb impairment,
a slight improvement have been reported using robot-assisted
rehabilitative treatment, even years after a stroke (Lo et al.,
2010). Another innovative approach for the enhancement of
motor recovery is represented by non-invasive human brain
stimulation techniques, such as repetitive transcranial magnetic
stimulation (rTMS) and transcranial direct current stimulation
(tDCS). These techniques can induce long-lasting changes
in the excitability of central motor circuits via long-term
potentiation/depression (LTP/LTD)-like phenomena (Di Pino
et al., 2014b). A recent study reported a mild motor improvement
after 10 sessions of rTMS in a group of severe chronic stroke
patients (Demirtas-Tatlidedea et al., 2015).
Aim of present study was to explore whether the combination
of these two approaches might enhance their positive effects on
motor recovery. To the end of assessing safety and potential
efficacy of the combination of robot-assisted rehabilitation and
non-invasive brain stimulation in a group of chronic stroke
patients with severe upper limb impairment, we designed
a proof-of-principle double blinded semi-randomized sham-
controlled trial. We used continuous theta burst stimulation
(cTBS), a robust form of inhibitory rTMS inducing LTD-like
changes lasting for about 1 h [8]. The choice of employing cTBS
on the affected hemisphere was based on the findings of our
recent study, which suggested that this inhibitory protocol can
improve the response to physical therapy (Di Lazzaro et al.,
2013).Moreover, rTMS protocols suppressing cortical excitability
have been shown to strongly facilitate motor learning in normal
subjects (Jung and Ziemann, 2009). Jung and Ziemann suggested
that such enhancement might involve the phenomenon of
“homeostatic” plasticity, which can be induced in the human
brain using a variety of brain stimulation protocols (Karabanov
et al., 2015). Considering the close link between LTP and
mammalian learning and memory (Malenka and Bear, 2004),
an enhancement of learning after LTD induction might appear
a paradox. However, the experimental studies by Rioult-Pedotti
et al. demonstrated the existence of a homeostatic balance
between learning and the induction of LTP/LTD (Rioult-Pedotti
et al., 2000), thus showing that the ease of producing synaptic
LTP/LTD depends on the prior history of neural activity. In the
context of stroke, this predicts that by delivering a rTMS protocol
that induces LTD-like effects on the stroke-affected hemisphere
before performing rehabilitation, would luckily result in better
relearning (Di Pino et al., 2014a).
MATERIALS AND METHODS
Subjects
The study was performed according to the Oviedo Convention
and approved by the Ethics Committee of Università Campus
Bio-Medico of Rome. Participants provided written informed
consent. Inclusion criteria were: (a) first-ever ischemic stroke
at least 1 year earlier; (b) severe hand function impairment,
defined as score of 3–28 on the Fugl-Meyer Assessment
of sensory motor recovery after stroke, a scale with scores
for upper-limb impairment ranging from 0 (no function) to
66 (normal function); (c) ability to give informed consent
and comprehend instructions. Exclusion criteria were: (a)
concomitant neurological conditions, including any history of
epilepsy and significant comorbidities; (b) cognitive impairment
or any substantial decrease in alertness, language reception, or
attention that might interfere with understanding instructions
for motor testing; (c) apraxia; (d) excessive pain in any joint
of the paretic extremity; (e) contraindications to TMS such
as metal head implants; (f) advanced liver, kidney, cardiac or
pulmonary disease; (g) history of significant alcohol or drug
abuse; (h) depression or use of neuropsychotropic drugs such
as antidepressants or benzodiazepines. The National Institute of
Health Stroke Scale (NIHSS) and the Barthel Index (BI) were
used to evaluate neurological impairment and disability at the
enrolment.
The study was proposed to patients attending the outpatient
clinic for cerebrovascular disorders of Campus Bio-Medico
University Hospital. From April the first, 2013, to September
the 30th, 2014, we screened 143 patients, 13 of whom declined,
110 were excluded, and 20 underwent randomization (Figure 1).
Common reasons for exclusion of patients from the study were
a baseline Fugl-Meyer score outside the required range, history
of epilepsy, and haemorrhagic stroke. Other causes of exclusion
were previous ischemic strokes, stroke occurring <1 year before,
severe cognitive impairment, contraindications to TMS such as
metal head implants or pacemaker, use of neuropsychotropic
drugs such as antidepressants or benzodiazepines.
Experimental Design
Ten patients were randomized to robot-assisted therapy
associated with real cTBS and 10 patients to robot-assisted
therapy associated with sham cTBS, through a randomization
stratification approach. Patients were stratified by using at
baseline measures to ensure that both groups had a similar
distribution regarding degree of impairment. Researcher
randomizing patients and researchers delivering cTBS were not
involved in outcome assessments and data analysis; rehabilitation
doctors, patients, and researchers involved in data analysis were
blind to the type of cTBS delivered (i.e., sham or real), in order
to obtain a double-blinded sham-controlled study design.
Each day, for 10 consecutive working days, each patient
received a session of robotic therapy following the real or
sham stimulation. Patients were evaluated at four time points:
baseline (Baseline), just after the treatment (Post), after 1 (1
Month), and 3 months (3 Months). For all these evaluation
points we assessed the Fugl-Meyer score and Robotic measures
of motor performance (Figure 1). At baseline we also included
the following scales: NIHSS, Rankin Scale, Barthel Index, and
Modified Ashworth Scale (MAS). Spasticity was assessed by MAS
at four different joint of affected arm: shoulder, elbow, wrist, and
fingers. For each patient, a cumulative score was obtained by
summing the scores obtained in the four joints. The cumulative
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FIGURE 1 | Figurative illustration representing the algorithm of the study design, the evaluations carried out, and the treatments delivered. Treatment
(real/sham cTBS + physical therapy) was delivered for 10 consecutive working days. Baseline evaluation was performed in the first day of treatment.
score ranges from 0 (no spasticity) to 16 (maximum spasticity,
i.e., score 4 in all the considered joints).
The combined effect of robotic rehabilitation and brain
stimulation was evaluated on (a) the Fugl Meyer score after
intervention, as compared to baseline (primary outcomemeasure
of clinical improvement) and (b) robot derived measures of
motor performance (secondary outcome measures).
After the 2 weeks of intervention, patients did not receive
any additional physical therapy until the last follow-up
visit (at 3 months). Pharmacological therapy was also
unchanged.
Interventions
Transcranial Brain Stimulation
rTMS was applied over the hand motor area of the affected
hemisphere using a DUOMAG XT stimulator (DEYMED
Diagnostic, Czech Republic) and a figure-of-eight shaped
coil, with the handle pointed posteriorly and approximately
perpendicular to the central sulcus.
Active rTMS used cTBS, in which 3 pulses are given at 50Hz,
repeated every 200ms for a total of 600 pulses. Stimulation
intensity was 80% active motor threshold (AMT) of the affected
hemisphere, defined as the minimum single pulse intensity
required to produce a motor evoked potential >200µV on
more than 5 out of 10 trials from the contracted contralateral
first dorsal interosseous muscle. Whenever AMT over the
affected hemisphere could not be determined because TMS at
maximum stimulator output (MSO) failed to evoke any response,
cTBS intensity was performed at an intensity corresponding to
unaffected hemisphere AMT. Sham rTMS was performed using
the same stimulator at an intensity of 3% of MSO and with
the coil tilted at 90◦; this intensity of stimulation, with this
orientation of the coil, produces auditory sensation similar to the
active stimulation, but has no stimulating effect on the cortex.
Robotic Therapy
The Robot was exploited for the two-fold purpose of delivering
therapy and measuring, objectively and quantitatively, patients’
motor performance. Shoulder-elbow robotic therapy was
delivered with the InMotion2 robotic machine (Interactive
Motion Technologies, Inc.) (Krebs et al., 1998). The InMotion2
(Figure 2) is based on a direct-drive five-bar-linkage SCARA
mechanism that provides two translational degrees of freedom
for elbow and forearm motion. Impedance control enables
the robot to move, guide or perturb the patient’s movement.
Absolute encoders at each motor and a 6-axis force/torque sensor
at the end effector allow measuring robot joint position, robot
Cartesian position (via forward kinematics) and interaction
forces.
In the evaluation phase, the robot was completely passive
while position sensors recorded subject kinematic data. Patients
were asked to perform five blocks of unassisted 16 point-to-point
movements from the center to eight outbound targets along a
circle at a distance of 0.14 m. Patients were required to move with
a self-paced speed in a maximum time slot of 3 s.
Robot data were oﬄine processed to compute quantitative
indicators of temporal and spatial features of motor skill recovery
(Zollo et al., 2011a; Papaleo et al., 2013), i.e.:
Motion Accuracy—It is assessed by means of the area index
and the normalized mean deviation, defined below:
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FIGURE 2 | The InMotion2 robotic machine (Interactive Motion
Technologies, Inc.).
- AREA. It is the area between the desired and the actual
trajectory performed by the patient in the XY plane during the
point-to-point motion; it is expected to decrease as movement
accuracy increases with recovery.
- normalized Mean Deviation (nMD) (Colombo et al., 2008).
It is the mean absolute value of the distance between the
desired path and the curve actually performed by the patient,
normalized on the maximum deviation (or on the length of the
theoretical path). As the patient recovers, the deviation from
the desired path is expected to decrease;
Motion Direction—It is assessed through the aiming angle,
i.e., the angular difference between the target direction and the
direction of the path performed from the starting point up
to peak speed point. It is expected to decrease as movement
direction improves during recovery;
Smoothness (Rohrer et al., 2002)—It is a measure of how
gradually amovement is changing and it is characterized by peaks
and deep valleys in the velocity profile. Smoothness is quantified
through the indicators reported below:
- Speed Metric (SM). It is expressed as the ratio between mean
speed and peak speed. As patient recovers, the normalized
mean velocity increases due to the reduction of peaks and
valleys in the velocity profile;
- Mean Arrest Period Ratio (MAPR). It represents the amount of
time (i.e., the percentage of samples) that the movement speed
exceeds the 10% of the peak speed. The deep valleys (percentage
of pauses during the task execution) in the velocity profile of the
patient hand are expected to reduce as movement smoothness
improves.
Speed—It quantifies the movement velocity by measuring
the Deviation from Ratio between Velocities (DRV), defined as
the absolute deviation of the ratio between peak velocity and
mean velocity from the constant value 1.875 (corresponding to
the value obtained in the minimum jerk trajectory) (Flash and
Hogan, 1985). It is expected to reduce when patient velocity
tends to the bell-shaped velocity profile of the minimum jerk
trajectory.
Movement Duration (MD)—It gives a measure of the task
execution time, evaluated as the time occurred for performing
a point-to-point movement from movement onset to movement
termination. Movement onset is defined as the time instant
where speed exceeds a predefined threshold of 10% of peak
velocity and movement termination is defined as the time
instant where velocity goes below a predefined threshold of
10% of peak velocity. As patient recovers, movement duration
is expected to decreases as a consequence of the improved
efficiency.
Efficiency—It evaluated the measure of patient ability to reach
the target during point-to-point movement; it can be assessed by
means of the path length index and the percentage of successes:
- Path Length (PL). It is defined as the length ratio between the
actual patient curve and the desired straight line, and computed
as the line integral of the trajectory over the Movement
Duration (MD), normalized with respect to the desired path. It
is expected that during recovery the actual patient curve tends
to the desired path and, hence, their ratio tends to one;
- % Successes (SR) (Panarese et al., 2012). It represents the
percentage of times that the patient reaches the target during
a therapy session of point-to-point movements. The increase
of the SR with recovery is expected.
Each day of robotic treatment consisted of three sessions of
320 assisted point-to-point movements, from the center to eight
outbound targets, interspersed by four sessions of 16 unassisted
recorded point-to-point movements. Robot assistance at each
session was tuned on patients’ performance during the 16 point-
to-point sessions. Both during evaluations and during training,
patients were required to move with a self-paced speed in a
maximum time slot of 3 s. Robotic treatment was delivered daily
for 10 consecutive working days. A physical and rehabilitation
medicine doctor attended and assisted patients both during
evaluations and treatment.
Statistics
Statistical analysis was performed using IBM SPSS v22. We
verified that at baseline the two groups were matched regarding
age, sex, and clinical status. Then we investigated the effect
of brain stimulation and robotic rehabilitation on the primary
outcome measure, namely Fugl-Meyer scores, using an ANOVA
mixed model design, with Time (four levels: Baseline, Post, 1
Month, 3 Months) as within subject factor and Group (two
levels: real cTBS and sham cTBS) as between subjects factor. For
the secondary outcome measures (robot derived measures) we
applied a Generalized Estimating Equation approach, as multiple
values were available for each cell of the design (Pellegrino
et al., 2012; Di Lazzaro et al., 2014). The autoregressive (lag =
1) working correlation within subjects was chosen because
measures of motor performance were acquired consecutively.
The study of the Success Rate was performed by means of
the Chi-Square test. The level of significance was set at p <
0.05 and the alpha inflation due to multiple comparisons was
faced according to Bonferroni’s procedure whenever required.
Descriptive statistics is reported as Mean± Standard Error of the
Mean (SE).
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TABLE 1 | Demographic and clinical characteristics of the patients at
baseline.
Real cTBS (n = 8) Sham cTBS (n = 9) P-value
Age (years) 57.88 ± 4.434 56.78 ± 3.202 0.841
Sex (M) 4 4 1.000a
Months since stroke 63.25 ± 25.437 61.33 ± 14.716 0.541b
NIHSS 5.50 ± 0.779 5.00 ± 0.687 0.636c
Rankin 2.88 ± 0.350 3.00 ± 0.333 0.815b
Barthel index 76.88 ± 7.130 77.22 ± 4.648 0.743b
Modified ashworth scale
cumulative score*
5.00 ± 0.597 7.111 ± 1.160 0.140c
Fugl-Meyer 14.50 ± 2.428 12.56 ± 2.243 0.565c
All data are expressed as mean ± standard error.
aChi-Square.
bMann-Whitney.
cTwo tailed independent sample t-test.
*Cumulative score was obtained by summing the scores obtained at four different joints
of affected arm: shoulder, elbow, wrist, and fingers.
RESULTS
Twenty patients underwent randomization (14% of the screened
patients): 10 to robot-assisted therapy associated with real cTBS
and 10 to robot-assisted therapy associated with sham cTBS.
One real patient withdrew consent before the first session of
treatment. One real patient and 1 sham patient withdrew because
of difficulty in reaching the hospital after the third and after the
fifth day of treatment, respectively. Data of these patients was
not included in the analysis. A total of 17 patients completed
the study including the 3 month follow-up: 8 real cTBS patients
(mean age: 57.8± 4.4 years) and 9 sham cTBS (mean age: 56.7±
3.2 years), therefore, 85% of the screened patients completed the
study. For the purposes of the study we applied an on-treatment
analysis (Figure 1). The real and sham groups were matched
regarding age, sex, time elapsed from stroke onset, and clinical
status at baseline (Table 1).
Physicians inquired about adverse events and pain, each day
during the whole stimulation period (10 consecutive working
days) and at each outward control. There were no treatment-
related adverse events. No patient reported pain in the affected
arm subsequent to treatment or required to stop treatment
session for pain or any other unpleasant sensation. In particular,
patients reported no side effects that could be related either to
the robotic treatment (e.g., shoulder, elbow, or wrist pain) or
to cTBS (seizure, syncope, transient headache, local pain, neck
pain, transient cognitive/neuropsychologial changes; Rossi et al.,
2009).
Primary Outcome Measure
The ANOVA Mixed Model with Time (four levels: Baseline,
Post, 1 Month, 3 Months) as within subject factor and Group
(two levels: real cTBS and sham cTBS) as between subjects
factor revealed a significant effect of rehabilitation [FactorTime:
F(1.613, 22.586) = 5.801, p = 0.013], but no effect of the
brain stimulation (Factor Group and Group by Time interaction:
p > 0.200 consistently). The improvement vs. baseline was
FIGURE 3 | Changes in the primary Outcome Measure (Fugl-Meyer
Assessment score) in the Real (red line) and the Sham (green line)
cTBS groups. Compared to Baseline both groups significantly improved at t1
(post-treatment) and t2 (1 month). There is no significant difference between
groups. *p < 0.05.
statistically significant both soon after the intervention (Post)
and at 1 Month follow-up (Bonferroni corrected post-hoc p =
0.30, p = 0.19, respectively). At 3 Months there was an
average additional increase of the Fugl-Meyer score, however
the difference toward Baseline was not significant (Bonferroni
corrected post-hoc p = 0.75) (Figure 3).
Secondary Outcome Measures
Motion Accuracy, Motion Direction, Smoothness,
Speed, Movement Duration
The main finding was a rehabilitation-related improvement
of the motor performance across multiple domains, including
Motion Accuracy, Motion Direction, Smoothness, Speed, and
Movement Duration. In particular all the robot-derivedmeasures,
except normalized Mean Deviation (nMD), consistently showed
a significant factor Time (Area: Wald Chi-Square= 28.019, df =
3, p = 0.000; Aiming angle (alpha): Wald Chi-Square = 44.608,
df = 3, p = 0.000; Speed Metric (SM): Wald Chi-Square
= 126.045, df = 3, p = 0.000; Mean Arrest Period Ratio
(MAPR):Wald Chi-Square = 2.796, df = 3, p = 0.000; DRV :
Wald Chi-Square = 20.275, df = 3, p = 0.000; Movement
Duration (MD): Wald Chi-Square = 52.088, df = 3, p = 0.000).
The Bonferroni corrected comparisons at all the time points
toward Baseline showed a consistent and persistent improvement
for all these measures (Post intervention, at 1 Month and at 3
Months, p < 0.05 consistently). The lack of significant main
factor Group and Group by Time interaction ruled out an effect
of cTBS on these parameters (Figure 4).
Efficiency
The study of the efficiency showed that cTBS over the affected
hemisphere has an impact on the improvement of motor
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FIGURE 4 | Changes in the Secondary Outcome Measures (motor performance parameters extracted by the robot) in the Real (red line) and the Sham
(green line) cTBS groups. Compared to Baseline both groups significantly improved at t1 (post-treatment), t2 (1 month), and t3 (3 months) *p < 0.05. There is no
difference between groups.
performance produced by the rehabilitation. Such effect was not
unveiled by the measure of the path length (PL), for which both
main Factors and interaction were not significant, but became
clear at the analysis of the Success Rate. Indeed, the number of
errors at Baseline (across groups) was 593 and decreased after
the intervention, being 342 at Post, 364 at 1 Month, and 313 at
3 Months. However, the improvement was different in the two
cTBS groups (Chi-Square = 35.576, df = 3, p = 0.000). The
Real cTBS group showed a higher error number (337 vs. 256, Std.
Residual −2.4) at Baseline. However, in spite of this, the study
of the residuals revealed that, compared to the cTBS group, the
errors were significantly more in the sham 1 at Post (Real cTBS
136, Sham cTBS 206, Std. Residuals >1.9) and 1 Month (Real
cTBS 155, Sham cTBS 209, Std residuals = 1.9). Such effect was
no more present at 3 Months (3 Months; Real cTBS 170, Sham
cTBS 143, Std residuals= 1.2) (Figure 5).
DISCUSSION
The present study shows that a robot-assisted rehabilitation
protocol lasting 2 weeks produces a slight, but significant, clinical
improvement in chronic stroke patients with severe upper limb
motor deficits.
This study also shows that non-invasive brain stimulation
delivered as cTBS over the affected hemisphere does not enhance
the clinical gains from this treatment. Indeed, considering
the primary outcome, there was no significant difference
between real and sham-cTBS patients. The improvement in
Fugl-Meyer was significant for both groups immediately after
the intervention and at 1 month follow-up, while it was
not significant at 3 months. At 3 months there was a
slight further increase in the average scores, and the lack of
significance was probably due to the high variability of the
measures.
The mean change in the Fugl-Meyers score was rather limited,
about 5% (3–4 points). However, this might be considered
meaningful in chronic patients, especially in those with severe
impairment (Lo et al., 2010). In a more general sense, a minimum
increase of about five points is required to make a clinically
significant difference (Page et al., 2012), but this threshold was
established in patients with minimum to moderate impairment
and does not fit well with our group of patients with severe
impairment.
It should also be noted that, assuming that a Fugl-Meyers
score difference of at least four points is of clinical interest, in
order to find a significant difference between our two groups a
much larger sample size might be needed (50 patients per group,
Power= 80%, Type I error= 0.05). In any case, the percentage of
the patients assigned to real cTBS who achieved a gain of at least
five points, was slightly higher than the percentage of patients
who achieved this gain in the sham group [3 out of 8 (38%) in
the real group vs. 2 out of 9 (22%) in the sham group].
Interestingly, the mean improvement in the Fugl-Meyer
score is comparable to what has been achieved previously
with longer lasting interventions (12 weeks with 36 1-hour/day
sessions of robot-assisted rehabilitative therapy in the study
of Lo et al., 2010); 8 weeks with a total 24 sessions in the
study by Klamroth-Marganska et al. (2014). In contrast with
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FIGURE 5 | Changes in the Success Rate, a secondary Outcome
Measure broader measure of motor performance representing the
percentage of times that the patient reaches the target. The
improvement in the real cTBS group was higher than in the sham group at t1
(post-treatment) and t2 (1 month). *p < 0.05.
present findings, our previous study in chronic stroke patients
with moderate upper limb deficits suggested that cTBS might
enhance the gain from a late rehabilitation with a standardized
protocol of physical rehabilitation (Di Lazzaro et al., 2013). One
possible explanation for this discrepancy is that robot assisted
rehabilitation attains a maximal benefit in patients with severe
deficits and this cannot be enhanced by brain stimulation because
of a ceiling effect. Another possibility, is that, as suggested by
Daly et al. (2005), a more prolonged robotic therapy is needed
to obtain a consistent improvement in patients with severe
impairment and thus, it cannot be excluded that prolonging
the association of robotic treatment and brain stimulation for
a longer period might result more effective. Finally, a further
possibility could arise from the fact that the affected and
unaffected hemispheres seems to play a different role in mild
vs. severe strokes, so that the hemisphere mainly responsible for
motor recovery in severe stroke is the unaffected one (Di Pino
et al., 2014b). If this is the case, in patients with severe brain
damage, it may be not useful to attempt to promote ipsilesional
reorganization because the manipulation of the excitability of
the affected hemisphere may not produce any advantage in
terms of promoting relearning from rehabilitation. Instead, in
these patients, our future efforts should target the unaffected
hemisphere being its role in recovery more relevant (Di Pino
et al., 2014b).
It should be considered that, for safety concerns, stimulus
intensity was estimated from the unaffected hemisphere, because
this might be hyperexcitable (Di Lazzaro et al., 2010), it might
be that this intensity was below the one needed to activate
intracortical networks of the affected hemisphere. Although cTBS
after effects are produced by stimulus intensities well below
motor threshold (Huang et al., 2005), and although this intensity
produced significant effects in our previous study in patients with
less severe stroke (Di Lazzaro et al., 2013), we cannot exclude that
higher intensity cTBS could produce a more pronounced effect
also in patients with severe stroke.
The study of the robotic measures of motor performance
(secondary outcomes) allowed us a more sensitive and accurate
evaluation of the effects of robotic rehabilitation and brain
stimulation on motor recovery (Pellegrino et al., 2012). These
measures complement the clinical scales and show that our
rehabilitation strategy achieves a significant benefit up to 3
months after the end of the treatment, confirming previous
studies (Prange et al., 2006; Kwakkel et al., 2008; Lo et al.,
2010). A significant improvement was achieved in multiple
domains of motor control in both groups (Motion accuracy,
Motion Direction, Smoothness, Speed, Movement Duration,
Success Rate) with no significant difference between groups.
Only the Success Rate, representing the percentage of times that
the patient reaches the target, improved significantly more in
the real cTBS group than in the sham cTBS one: this might
suggest a mild benefit of cTBS on rehabilitation. Nevertheless,
this finding should be taken extremely cautiously, since the
difference between real and sham groups was not significant
on the other robot-derived measures. Despite the secondary
outcome measures have been analyzed in an independent
fashion, we cannot rule out that the Success Rate, being a
broader measure of motor performance, capitalizes the slight
improvements in multiple domains of motor control, resulting
statistically significant (Zollo et al., 2011a,b). However, it should
also be considered that the success rate was different at baseline
between the groups, this imbalance might influence the changes
observed in the two groups, and this is a further reason that led
to consider with caution the more pronounced improvement in
success rate after real cTBS.
CONCLUSIONS
Our study confirms that robot-assisted rehabilitative treatment
produces a slight improvement years after a stroke and it shows,
for the first time, that an improvement can be obtained even
in patients with severe upper-limb impairment treated daily for
only 10 working days. Moreover, it shows that non-invasive
brain stimulation delivered as cTBS of the affected hemisphere
to promote homeostatic metaplasticity, is not effective in patients
with severe deficits as those enrolled in present study, while
our previous study showed that this approach might be effective
in patients with moderate deficits. It might be that in severe
patients the unaffected hemisphere is more involved in recovery,
thus, the modulation of the excitability of this hemisphere could
produce positive effects. In these patients, it could also be that
the facilitation of the affected hemisphere is more effective
than inhibition. Also, it might be that different strategies for
promoting homeostatic plasticity might produce positive effects
(e.g., protocols of so-called primed stimulation in which low-
frequency rTMS is preceded by a bout of high-frequency rTMS;
Cassidy et al., 2015).
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The implementation of non-invasive brain stimulation
techniques as an additional tool to promote recovery in chronic
stroke patients requires further studies in order to identify the
subgroups of patients that most likely will respond to a particular
intervention.
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